These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 32909326

  • 1. Effect of sour tea supplementation on liver enzymes, lipid profile, blood pressure, and antioxidant status in patients with non-alcoholic fatty liver disease: A double-blind randomized controlled clinical trial.
    Izadi F, Farrokhzad A, Tamizifar B, Tarrahi MJ, Entezari MH.
    Phytother Res; 2021 Jan; 35(1):477-485. PubMed ID: 32909326
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Oral coenzyme Q10 supplementation in patients with nonalcoholic fatty liver disease: effects on serum vaspin, chemerin, pentraxin 3, insulin resistance and oxidative stress.
    Farhangi MA, Alipour B, Jafarvand E, Khoshbaten M.
    Arch Med Res; 2014 Oct; 45(7):589-95. PubMed ID: 25450583
    [Abstract] [Full Text] [Related]

  • 4. Effect of Portulaca Oleracea (purslane) extract on liver enzymes, lipid profile, and glycemic status in nonalcoholic fatty liver disease: A randomized, double-blind clinical trial.
    Darvish Damavandi R, Shidfar F, Najafi M, Janani L, Masoodi M, Akbari-Fakhrabadi M, Dehnad A.
    Phytother Res; 2021 Jun; 35(6):3145-3156. PubMed ID: 33880813
    [Abstract] [Full Text] [Related]

  • 5. The effects of green cardamom on blood glucose indices, lipids, inflammatory factors, paraxonase-1, sirtuin-1, and irisin in patients with nonalcoholic fatty liver disease and obesity: study protocol for a randomized controlled trial.
    Daneshi-Maskooni M, Keshavarz SA, Mansouri S, Qorbani M, Alavian SM, Badri-Fariman M, Jazayeri-Tehrani SA, Sotoudeh G.
    Trials; 2017 Jun 07; 18(1):260. PubMed ID: 28592311
    [Abstract] [Full Text] [Related]

  • 6. Cinnamon may have therapeutic benefits on lipid profile, liver enzymes, insulin resistance, and high-sensitivity C-reactive protein in nonalcoholic fatty liver disease patients.
    Askari F, Rashidkhani B, Hekmatdoost A.
    Nutr Res; 2014 Feb 07; 34(2):143-8. PubMed ID: 24461315
    [Abstract] [Full Text] [Related]

  • 7. A comparative study of the effect of green tea and sour tea on blood pressure and lipid profile in healthy adult men.
    Kafeshani M, Entezari MH, Karimian J, Pourmasoumi M, Maracy MR, Amini MR, Hadi A.
    ARYA Atheroscler; 2017 May 07; 13(3):109-116. PubMed ID: 29147120
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of dietary polyphenol supplementation in the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Yang K, Chen J, Zhang T, Yuan X, Ge A, Wang S, Xu H, Zeng L, Ge J.
    Front Immunol; 2022 May 07; 13():949746. PubMed ID: 36159792
    [Abstract] [Full Text] [Related]

  • 9. Effect of garlic powder supplementation on hepatic steatosis, liver enzymes and lipid profile in patients with non-alcoholic fatty liver disease: a double-blind randomised controlled clinical trial.
    Sangouni AA, Mohammad Hosseini Azar MR, Alizadeh M.
    Br J Nutr; 2020 Aug 28; 124(4):450-456. PubMed ID: 32312333
    [Abstract] [Full Text] [Related]

  • 10. Does naringenin supplementation improve lipid profile, severity of hepatic steatosis and probability of liver fibrosis in overweight/obese patients with NAFLD? A randomised, double-blind, placebo-controlled, clinical trial.
    Namkhah Z, Naeini F, Mahdi Rezayat S, Mehdi Yaseri, Mansouri S, Javad Hosseinzadeh-Attar M.
    Int J Clin Pract; 2021 Nov 28; 75(11):e14852. PubMed ID: 34516703
    [Abstract] [Full Text] [Related]

  • 11. The effects of Zataria multiflora Boiss. (Shirazi thyme) on nonalcoholic fatty liver disease and insulin resistance: A randomized double-blind placebo-controlled clinical trial.
    Zamani N, Shams M, Nimrouzi M, Zarshenas MM, Abolhasani Foroughi A, Fallahzadeh Abarghooei E, Fattahi MR.
    Complement Ther Med; 2018 Dec 28; 41():118-123. PubMed ID: 30477827
    [Abstract] [Full Text] [Related]

  • 12. Effect of Phytosomal Curcumin on Circulating Levels of Adiponectin and Leptin in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
    Mirhafez SR, Farimani AR, Dehhabe M, Bidkhori M, Hariri M, Ghouchani BF, Abdollahi F.
    J Gastrointestin Liver Dis; 2019 Jun 01; 28():183-189. PubMed ID: 31204416
    [Abstract] [Full Text] [Related]

  • 13. Standardized Nigella sativa seed oil ameliorates hepatic steatosis, aminotransferase and lipid levels in non-alcoholic fatty liver disease: A randomized, double-blind and placebo-controlled clinical trial.
    Khonche A, Huseini HF, Gholamian M, Mohtashami R, Nabati F, Kianbakht S.
    J Ethnopharmacol; 2019 Apr 24; 234():106-111. PubMed ID: 30639231
    [Abstract] [Full Text] [Related]

  • 14. Olive oil lessened fatty liver severity independent of cardiometabolic correction in patients with non-alcoholic fatty liver disease: A randomized clinical trial.
    Rezaei S, Akhlaghi M, Sasani MR, Barati Boldaji R.
    Nutrition; 2019 Jan 24; 57():154-161. PubMed ID: 30170304
    [Abstract] [Full Text] [Related]

  • 15. Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease.
    Faghihzadeh F, Adibi P, Rafiei R, Hekmatdoost A.
    Nutr Res; 2014 Oct 24; 34(10):837-43. PubMed ID: 25311610
    [Abstract] [Full Text] [Related]

  • 16. Functions of Coenzyme Q10 Supplementation on Liver Enzymes, Markers of Systemic Inflammation, and Adipokines in Patients Affected by Nonalcoholic Fatty Liver Disease: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
    Farsi F, Mohammadshahi M, Alavinejad P, Rezazadeh A, Zarei M, Engali KA.
    J Am Coll Nutr; 2016 Oct 24; 35(4):346-53. PubMed ID: 26156412
    [Abstract] [Full Text] [Related]

  • 17. The effect of sesame oil consumption compared to sunflower oil on lipid profile, blood pressure, and anthropometric indices in women with non-alcoholic fatty liver disease: a randomized double-blind controlled trial.
    Vahedi H, Atefi M, Entezari MH, Hassanzadeh A.
    Trials; 2022 Jul 08; 23(1):551. PubMed ID: 35804451
    [Abstract] [Full Text] [Related]

  • 18. Effect of l-carnitine supplementation on children and adolescents with nonalcoholic fatty liver disease (NAFLD): a randomized, triple-blind, placebo-controlled clinical trial.
    Saneian H, Khalilian L, Heidari-Beni M, Khademian M, Famouri F, Nasri P, Hassanzadeh A, Kelishadi R.
    J Pediatr Endocrinol Metab; 2021 Jul 27; 34(7):897-904. PubMed ID: 33939897
    [Abstract] [Full Text] [Related]

  • 19. Effects of Delta-tocotrienol Supplementation on Liver Enzymes, Inflammation, Oxidative stress and Hepatic Steatosis in Patients with Nonalcoholic Fatty Liver Disease.
    Pervez MA, Khan DA, Ijaz A, Khan S.
    Turk J Gastroenterol; 2018 Mar 27; 29(2):170-176. PubMed ID: 29749323
    [Abstract] [Full Text] [Related]

  • 20. The effects of grape seed extract supplementation on cardiovascular risk factors, liver enzymes and hepatic steatosis in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study.
    Ghanbari P, Raiesi D, Alboebadi R, Zarejavid A, Dianati M, Razmi H, Bazyar H.
    BMC Complement Med Ther; 2024 May 16; 24(1):192. PubMed ID: 38755622
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.